The 12 closest competitors and alternatives to Resistell among biotechnology companies — ranked by similarity to what Resistell actually does, not by market-cap band.
Subscribe to see Resistell’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Headquartered in Muttenz, Switzerland, Resistell AG is a biotechnology company incorporated in 2018 that develops rapid antibiotic susceptibility testing devices as an innovative alternative to traditional culture-based antibiograms.
Resistell is a biotechnology company headquartered in Switzerland. Its most recent funding round, Series B, raised $9.1M in December 2022. Xcout tracks 25 named people at Resistell, including Grzegorz Gonciarz (COO).
19 more named people on record for Resistell, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $9.1M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Resistell by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Medical Diagnostics
Sysmex Astrego is a medical technology company specializing in automated antibiotic susceptibility testing to combat antimicrobial resistance.
Medical Diagnostics
Affinity Biosensors manufactures the LifeScale system, a medical technology product that provides rapid antimicrobial susceptibility testing (AST) results for gram-negative bacteria from positive blood cultures. The system uses population-profiling technology to deliver laboratory test results in approximately four hours to assist medical and laboratory professionals.
Similar biotechnology company
BIOPIX-T is a certified medical technology company based in Heraklion, Crete, Greece, that specializes in the design, development, and production of molecular diagnostic platforms like PEBBLE qcLAMP.
Similar biotechnology company
Royal Biotech Inc. develops, manufactures, and markets portable diagnostic analysis products, handheld systems, and test kits for clinical, veterinary, food safety, and environmental applications. The company serves public security and health sectors by providing molecular and microfluidic diagnostic devices designed for on-site use.
Medical Technology
Magnolia Medical Technologies, Inc. is a medical device company headquartered in Seattle and Bellevue, Washington. The company develops diagnostic and blood collection technologies designed to reduce in-vitro diagnostic errors and improve blood culture accuracy.
Diagnostics
iFAST Diagnostics is a United Kingdom-based diagnostics company developing low-cost, high-throughput rapid antimicrobial susceptibility testing (AST) technology. The firm focuses on combating antimicrobial resistance globally with a team of 11 to 50 employees.
Diagnostics
Day Zero Diagnostics is a biotechnology company developing rapid, sequencing-based diagnostic tests to identify bloodstream infections and predict antimicrobial resistance. Its products are intended for hospitals and clinicians managing seriously ill patients who need faster pathogen identification and antibiotic-selection information.
Similar biotechnology company
Day Zero Diagnostics, Inc. is a Boston-based company founded in 2016 that is pioneering a new class of infectious disease diagnostics using whole-genome sequencing and machine learning to address antibiotic resistance.
Medical Diagnostics
ABL Diagnostics is a French molecular-diagnostics company that develops in vitro diagnostic assays and bioinformatics software, including solutions for pathogen genotyping, treatment resistance and infectious-disease monitoring. Its products are used by clinical laboratories, hospitals and public-health or research organizations.
Diagnostics
Inflammatix, Inc. is a molecular diagnostics and biotechnology research company headquartered in Sunnyvale, California. It develops rapid point-of-care host-response diagnostic tests for suspected acute infections or sepsis.
Biotech
Detechgene is a Cologne, Germany-based biotechnology company founded in 2022 that specializes in molecular diagnostics and life sciences. The company develops rapid molecular testing platforms and cartridge systems designed for the precise detection of pathogens.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Resistelland every competitor above — in one live dashboard.
Subscribe to Xcout Intel →